Oral immunization with an rfaH mutant elicits protection against salmonellosis in mice

Infect Immun. 2004 Jul;72(7):4297-301. doi: 10.1128/IAI.72.7.4297-4301.2004.

Abstract

Loss of the transcriptional antiterminator RfaH results in virulence attenuation (>10(4)-fold increase in 50% lethal dose) of the archetypal Salmonella enterica serovar Typhimurium strain SL1344 by both orogastric and intraperitoneal routes of infection in BALB/c mice. Oral immunization with the mutant efficiently protects mice against a subsequent oral infection with the wild-type strain. Interestingly, in vitro immunoreactivity is not confined to strain SL1344; rather, it is directed also towards other serovars of S. enterica and even Salmonella bongori strains.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Escherichia coli Proteins / administration & dosage
  • Escherichia coli Proteins / genetics
  • Escherichia coli Proteins / immunology*
  • Mice
  • Mutation
  • Peptide Elongation Factors / administration & dosage
  • Peptide Elongation Factors / genetics
  • Peptide Elongation Factors / immunology*
  • Salmonella Infections, Animal / immunology*
  • Salmonella Infections, Animal / prevention & control
  • Salmonella Vaccines / administration & dosage
  • Salmonella Vaccines / genetics
  • Salmonella Vaccines / immunology*
  • Salmonella typhimurium / genetics
  • Salmonella typhimurium / pathogenicity*
  • Trans-Activators / administration & dosage
  • Trans-Activators / genetics
  • Trans-Activators / immunology*
  • Virulence

Substances

  • Escherichia coli Proteins
  • Peptide Elongation Factors
  • RfaH protein, E coli
  • Salmonella Vaccines
  • Trans-Activators